BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 27480145)

  • 1. Modified FOLFOX6 With or Without Radiation Versus Fluorouracil and Leucovorin With Radiation in Neoadjuvant Treatment of Locally Advanced Rectal Cancer: Initial Results of the Chinese FOWARC Multicenter, Open-Label, Randomized Three-Arm Phase III Trial.
    Deng Y; Chi P; Lan P; Wang L; Chen W; Cui L; Chen D; Cao J; Wei H; Peng X; Huang Z; Cai G; Zhao R; Huang Z; Xu L; Zhou H; Wei Y; Zhang H; Zheng J; Huang Y; Zhou Z; Cai Y; Kang L; Huang M; Peng J; Ren D; Wang J
    J Clin Oncol; 2016 Sep; 34(27):3300-7. PubMed ID: 27480145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase 2 study of preoperative radiation with concurrent capecitabine, oxaliplatin, and bevacizumab followed by surgery and postoperative 5-fluorouracil, leucovorin, oxaliplatin (FOLFOX), and bevacizumab in patients with locally advanced rectal cancer: ECOG 3204.
    Landry JC; Feng Y; Cohen SJ; Staley CA; Whittington R; Sigurdson ER; Nimeiri H; Verma U; Prabhu RS; Benson AB
    Cancer; 2013 Apr; 119(8):1521-7. PubMed ID: 23288663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and Safety of Preoperative Transcatheter Rectal Arterial Chemoembolisation in Patients with Locally Advanced Rectal Cancer: Results from a Prospective, Phase II PCAR Trial.
    Yang W; Qian C; Luo J; Chen C; Feng Y; Dai N; Li X; Xiao H; Yang Y; Li M; Li C; Wang D
    Clin Oncol (R Coll Radiol); 2024 Apr; 36(4):233-242. PubMed ID: 38342657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic effects of oxaliplatin-based neoadjuvant chemotherapy and chemoradiotherapy in patients with locally advanced rectal cancer: a single-center, retrospective cohort study.
    Okuyama T; Sameshima S; Takeshita E; Yoshioka R; Yamagata Y; Ono Y; Tagaya N; Noie T; Oya M
    World J Surg Oncol; 2018 Jun; 16(1):105. PubMed ID: 29871650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preoperative Treatment of Locally Advanced Rectal Cancer.
    Schrag D; Shi Q; Weiser MR; Gollub MJ; Saltz LB; Musher BL; Goldberg J; Al Baghdadi T; Goodman KA; McWilliams RR; Farma JM; George TJ; Kennecke HF; Shergill A; Montemurro M; Nelson GD; Colgrove B; Gordon V; Venook AP; O'Reilly EM; Meyerhardt JA; Dueck AC; Basch E; Chang GJ; Mamon HJ
    N Engl J Med; 2023 Jul; 389(4):322-334. PubMed ID: 37272534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alliance for clinical trials in oncology (ALLIANCE) trial A021501: preoperative extended chemotherapy vs. chemotherapy plus hypofractionated radiation therapy for borderline resectable adenocarcinoma of the head of the pancreas.
    Katz MHG; Ou FS; Herman JM; Ahmad SA; Wolpin B; Marsh R; Behr S; Shi Q; Chuong M; Schwartz LH; Frankel W; Collisson E; Koay EJ; Hubbard JM; Leenstra JL; Meyerhardt J; O'Reilly E;
    BMC Cancer; 2017 Jul; 17(1):505. PubMed ID: 28750659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Challenges and solutions in the design and execution of the PROSPECT Phase II/III neoadjuvant rectal cancer trial (NCCTG N1048/Alliance).
    Schrag D; Weiser M; Saltz L; Mamon H; Gollub M; Basch E; Venook A; Shi Q
    Clin Trials; 2019 Apr; 16(2):165-175. PubMed ID: 30688523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a biomarker profile associated with resistance to neoadjuvant chemoradiation therapy in rectal cancer.
    Garcia-Aguilar J; Chen Z; Smith DD; Li W; Madoff RD; Cataldo P; Marcet J; Pastor C
    Ann Surg; 2011 Sep; 254(3):486-92; discussion 492-3. PubMed ID: 21865946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rationale and Design of the IROCAS Study: Multicenter, International, Randomized Phase 3 Trial Comparing Adjuvant Modified (m) FOLFIRINOX to mFOLFOX6 in Patients With High-Risk Stage III (pT4 and/or N2) Colon Cancer-A UNICANCER GI-PRODIGE Trial.
    Bennouna J; André T; Campion L; Hiret S; Miglianico L; Mineur L; Touchefeu Y; Artru P; Asmis T; Bouché O; Borde F; Kavan P; Lam YH; Rajpar LS; Emile JF; Jouffroy C; Gill S; Taïeb J
    Clin Colorectal Cancer; 2019 Mar; 18(1):e69-e73. PubMed ID: 30415988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and efficacy of preoperative mFOLFOX6 regimen chemotherapy for locally resectable advanced rectal cancer.
    Liu L; Jiang Z
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2021 Jan; 46(1):32-38. PubMed ID: 33678634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Total neoadjuvant therapy with or without aflibercept in rectal cancer: 3-year results of GEMCAD-1402.
    Pesántez D; Ten Hoorn S; Machado I; García-Albéniz X; Rodríguez-Salas N; Heredia-Soto V; Viñal D; Pericay C; García-Carbonero R; Losa F; Alonso V; Vera R; Feliu Batlle J; Gallego J; Salud A; Nogué M; Layos L; Montagut C; Capdevila J; Vermeulen L; Maurel J; Fernandez-Martos C
    J Natl Cancer Inst; 2023 Dec; 115(12):1497-1505. PubMed ID: 37405857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CoCStom trial: study protocol for a randomised trial comparing completeness of adjuvant chemotherapy after early versus late diverting stoma closure in low anterior resection for rectal cancer.
    Sandra-Petrescu F; Herrle F; Hinke A; Rossion I; Suelberg H; Post S; Hofheinz RD; Kienle P
    BMC Cancer; 2015 Nov; 15():923. PubMed ID: 26589718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A complete response to mFOLFOX6 and panitumumab chemotherapy in advanced stage rectal adenocarcinoma: a case report.
    Sonoda H; Shimizu T; Mekata E; Endo Y; Ishida M; Tani T
    World J Surg Oncol; 2014 Mar; 12():63. PubMed ID: 24666666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The efficacy and safety of short-course radiotherapy followed by sequential chemotherapy and Cadonilimab for locally advanced rectal cancer: a protocol of a phase II study.
    Xu T; Feng L; Zhang W; Li H; Ma H; Abulimiti M; Tan Y; Deng F; Huang W; Zou S; Kang W; Jiang L; Wang Y; Hu C; Chen Y; Zhou H; Tang Y; Jin J
    BMC Cancer; 2024 Apr; 24(1):501. PubMed ID: 38641773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neoadjuvant Chemotherapy With Oxaliplatin and Fluoropyrimidine Versus Upfront Surgery for Locally Advanced Colon Cancer: The Randomized, Phase III OPTICAL Trial.
    Hu H; Zhang J; Li Y; Wang X; Wang Z; Wang H; Kang L; Liu P; Lan P; Wu X; Zhen Y; Pei H; Huang Z; Zhang H; Chen W; Zeng Y; Lai J; Wei H; Huang X; Chen J; Chen J; Tao K; Xu Q; Peng X; Liang J; Cai G; Ding K; Ding Z; Hu M; Zhang W; Tang B; Hong C; Cao J; Huang Z; Cao W; Li F; Wang X; Wang C; Huang Y; Zhao Y; Cai Y; Ling J; Xie X; Wu Z; Shi L; Ling L; Liu H; Wang J; Huang M; Deng Y;
    J Clin Oncol; 2024 Apr; ():JCO2301889. PubMed ID: 38564700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive multi-omics analysis of resectable locally advanced gastric cancer: Assessing response to neoadjuvant camrelizumab and chemotherapy in a single-center, open-label, single-arm phase II trial.
    Zhao Y; Li D; Zhuang J; Li Z; Xia Q; Li Z; Yu J; Wang J; Zhang Y; Li K; Xu S; Li S; Ma P; Cao Y; Liu C; Xu C; Liu Z; Wei J; Zhang C; Qiao L; Gao X; Hou Z; Liu C; Zheng R; Wang D; Liu Y
    Clin Transl Med; 2024 May; 14(5):e1674. PubMed ID: 38685486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized phase II study comparing preoperative mFOLFOX6 versus FOLFOXIRI for locally advanced colon cancer: JCOG2006.
    Hashimoto T; Maruyama S; Takii Y; Mizusawa J; Kataoka T; Fukuda H; Tsukamoto S; Takashima A; Hamaguchi T; Kanemitsu Y
    Future Oncol; 2023 Sep; 19(28):1897-1904. PubMed ID: 37750332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postoperative chemoradiotherapy in patients with locally advanced gastric cancer with poor pathologic response to neoadjuvant chemotherapy.
    Gal O; Lewin R; Perl G; Ulitzky O; Brenner B; Kundel Y
    J Cancer Res Ther; 2024 Jan; 20(1):281-284. PubMed ID: 38554334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemoradiotherapy with 5-fluorouracil/leucovorin, surgery and adjuvant chemotherapy for locally advanced rectal cancer.
    Baur M; Horvath M; Stättner S; Schratter-Sehn A; Horvath B; Sellner F; Hudec M; Klimpfinger M; Dittrich C; Karner J
    Oncol Lett; 2010 Jan; 1(1):189-194. PubMed ID: 22966281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neoadjuvant radiochemotherapy in the treatment of fixed and semi-fixed rectal tumors. Analysis of results and prognostic factors.
    Ferrigno R; Novaes PE; Silva ML; Nishimoto IN; Nakagawa WT; Rossi BM; Ferreira Fde O; Lopes A
    Radiat Oncol; 2006 Mar; 1():5. PubMed ID: 16722598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.